Skip to main content
. 2017 May 3;11(5):e0005560. doi: 10.1371/journal.pntd.0005560

Fig 1. Study design.

Fig 1

HCMB were enrolled during a period of 0–3 months after the beginning of their index case treatment. The first blood collection was performed prior to BCG vaccination according to the presence/absence of a BCG scar (T0). After an interval of 6 to 26 months from chemotherapy onset of the index case, the same individuals were asked to provide new peripheral blood samples (T1).